ARGA Investment Management LP Has $880,000 Stock Position in The Chemours Company $CC

Key Points

• ARGA Investment Management LP reduced its stake in The Chemours Company by 48.3%, now holding 76,821 shares valued at $880,000.
• Analysts show mixed sentiment towards Chemours, with five rating it as a Buy and two as a Sell, while the average target price is set at $18.50.
• The Chemours Company reported a 5.0% year-over-year revenue increase, with a revenue of $1.62 billion in its recent quarter, exceeding analyst estimates.

ARGA Investment Management LP lowered its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 48.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 76,821 shares of the specialty chemicals company's stock after selling 71,793 shares during the quarter. ARGA Investment Management LP owned 0.05% of Chemours worth $880,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. SouthState Corp acquired a new stake in Chemours in the 1st quarter valued at approximately $34,000. GAMMA Investing LLC lifted its stake in Chemours by 130.7% in the 2nd quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company's stock valued at $36,000 after purchasing an additional 1,799 shares during the last quarter. FNY Investment Advisers LLC lifted its stake in Chemours by 100.0% in the 2nd quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company's stock valued at $45,000 after purchasing an additional 2,000 shares during the last quarter. CWM LLC raised its stake in Chemours by 34.7% in the second quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company's stock valued at $49,000 after buying an additional 1,104 shares during the period. Finally, Parallel Advisors LLC raised its stake in Chemours by 132.6% in the second quarter. Parallel Advisors LLC now owns 5,634 shares of the specialty chemicals company's stock valued at $65,000 after buying an additional 3,212 shares during the period. 76.26% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on CC. Truist Financial increased their price target on Chemours from $18.00 to $21.00 and gave the company a "buy" rating in a research note on Tuesday, September 16th. Weiss Ratings reissued a "sell (d)" rating on shares of Chemours in a research report on Wednesday, October 8th. Zacks Research cut shares of Chemours from a "hold" rating to a "strong sell" rating in a research note on Friday, October 17th. UBS Group upped their price target on shares of Chemours from $17.00 to $21.00 and gave the company a "buy" rating in a research note on Monday, October 6th. Finally, Royal Bank Of Canada set a $19.00 price objective on shares of Chemours and gave the stock an "outperform" rating in a research report on Tuesday, October 14th. Five research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Chemours presently has a consensus rating of "Hold" and an average target price of $18.50.

Chemours Trading Up 2.5%

CC opened at $13.86 on Friday. The company has a quick ratio of 0.83, a current ratio of 1.68 and a debt-to-equity ratio of 17.16. The Chemours Company has a twelve month low of $9.13 and a twelve month high of $22.38. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of -4.95 and a beta of 1.65. The company has a 50-day simple moving average of $15.31 and a 200 day simple moving average of $13.06.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.12. Chemours had a negative net margin of 7.19% and a positive return on equity of 35.14%. The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter last year, the business posted $0.38 EPS. The firm's revenue for the quarter was up 5.0% on a year-over-year basis. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 15th were given a dividend of $0.0875 per share. The ex-dividend date was Friday, August 15th. This represents a $0.35 annualized dividend and a yield of 2.5%. Chemours's dividend payout ratio (DPR) is currently -12.50%.

Insiders Place Their Bets

In other Chemours news, CEO Denise Dignam purchased 4,068 shares of the business's stock in a transaction dated Friday, August 8th. The shares were bought at an average price of $12.06 per share, for a total transaction of $49,060.08. Following the completion of the acquisition, the chief executive officer owned 191,546 shares in the company, valued at approximately $2,310,044.76. This trade represents a 2.17% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.47% of the stock is owned by insiders.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.